Kim Soo-Kyung, Chen Yalu, Abrol Ravinder, Goddard William A, Guthrie Brian
Materials and Process Simulation Center (MC 139-74), California Institute of Technology, Pasadena, CA 91125;
Materials and Process Simulation Center (MC 139-74), California Institute of Technology, Pasadena, CA 91125.
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2568-2573. doi: 10.1073/pnas.1700001114. Epub 2017 Feb 22.
The sweet taste in humans is mediated by the TAS1R2/TAS1R3 G protein-coupled receptor (GPCR), which belongs to the class C family that also includes the metabotropic glutamate and γ-aminobutyric acid receptors. We report here the predicted 3D structure of the full-length TAS1R2/TAS1R3 heterodimer, including the Venus Flytrap Domains (VFDs) [in the closed-open (co) active conformation], the cysteine-rich domains (CRDs), and the transmembrane domains (TMDs) at the TM56/TM56 interface. We observe that binding of agonists to VFD2 of TAS1R2 leads to major conformational changes to form a TM6/TM6 interface between TMDs of TAS1R2 and TAS1R3, which is consistent with the activation process observed biophysically on the metabotropic glutamate receptor 2 homodimer. We find that the initial effect of the agonist is to pull the bottom part of VFD3/TAS1R3 toward the bottom part of VFD2/TAS1R2 by ∼6 Å and that these changes get transmitted from VFD2 of TAS1R2 (where agonists bind) through the VFD3 and the CRD3 to the TMD3 of TAS1R3 (which couples to the G protein). These structural transformations provide a detailed atomistic mechanism for the activation process in GPCR, providing insights and structural details that can now be validated through mutation experiments.
人类的甜味是由TAS1R2/TAS1R3 G蛋白偶联受体(GPCR)介导的,该受体属于C类家族,该家族还包括代谢型谷氨酸受体和γ-氨基丁酸受体。我们在此报告全长TAS1R2/TAS1R3异二聚体的预测三维结构,包括捕蝇草结构域(VFDs)[处于开闭(co)活性构象]、富含半胱氨酸结构域(CRDs)以及在TM56/TM56界面处的跨膜结构域(TMDs)。我们观察到,激动剂与TAS1R2的VFD2结合会导致主要的构象变化,从而在TAS1R2和TAS1R3的TMDs之间形成TM6/TM6界面,这与在代谢型谷氨酸受体2同二聚体上通过生物物理方法观察到的激活过程一致。我们发现,激动剂的初始作用是将VFD3/TAS1R3的底部部分朝着VFD2/TAS1R2的底部部分拉动约6 Å,并且这些变化从激动剂结合的TAS1R2的VFD2通过VFD3和CRD3传递到TAS1R3的TMD3(其与G蛋白偶联)。这些结构转变为GPCR的激活过程提供了详细的原子机制,提供了现在可通过突变实验进行验证的见解和结构细节。